Cuba vs Guatemala: HIV/AIDS deaths averted by antiretroviral therapy
Cuba
1,468 deaths
in 2024
Guatemala
1,666 deaths
in 2024
Cuba rank
65th
Guatemala rank
64th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Cuba
- Guatemala
How they compare
Guatemala currently reports 1,666 deaths against 1,468 deaths in Cuba, a difference of 198 deaths.
That makes Guatemala's figure about 1.1 times Cuba's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Guatemala ahead.
Cuba ranks 65th and Guatemala ranks 64th of 157 countries.
Guatemala has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Cuba | Guatemala | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 292.14 deaths | 674.44 deaths | 382.29 deaths | Guatemala |
| 2010s | 1,136 deaths | 1,601 deaths | 464.38 deaths | Guatemala |
| 2020s | 1,525 deaths | 1,629 deaths | 104.16 deaths | Guatemala |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Cuba or Guatemala?
- Guatemala, at 1,666 deaths against 1,468 deaths in Cuba as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Cuba and Guatemala?
- 198 deaths, with Guatemala ahead.
- How many years of comparable data are there for Cuba and Guatemala?
- 35 years are reported by both, from 1990 to 2024.
- How do Cuba and Guatemala rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Cuba ranks 65th and Guatemala ranks 64th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.